There are many ways to treat erectile dysfunction (ED), including prescription drugs such as Viagra and Cialis and nutritional supplements. A new treatment called pt 141 men is starting to get attention for its potential benefits in treating low libido and sexual desire. The peptide, also known as bremelanotide, acts differently from these traditional treatments because it doesn’t affect the vascular system but instead targets the nervous system to increase arousal and libido. It is administered via a nasal spray or subcutaneous injection and isn’t as well-established as the older drugs.
PT 141 is an agonist of melanocortin receptors, which typically control pigmentation and other body functions. Though most clinical studies have focused on women, there have been some small trials involving men that show promising results. One such trial found that a 33% of participants experienced positive changes in libido and sexual satisfaction when taking the hormone treatment. Other trial subjects reported an increase in the firmness and duration of their erections. There were also some low-risk side effects, such as nausea and flushing.
However, the peptide hasn’t yet been fully tested to see how it compares with drugs such as sildenafil or tadalafil, which have much more research behind them. Until more information is available, it’s best for men to stick with ED drugs that have been tested more extensively, like the PDE-5 inhibitors. Injections of pt 141 can be done at home, but it is important to use a sterile needle and syringe to avoid contamination.